A majority of up-to-date reviews addresses the association between circulating adiponectin levels and specific immune-mediated, rheumatic, or connective tissue diseases [3,4,5,6,7], or focuses on the role of adiponectin in the pathogenesis of these diseases [1,8,9,10]. The gene discussed is ADIPOQ; the disease is connective tissue disorder.